Cite
HARVARD Citation
Wirsching, H. et al. (2018). Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Annals of oncology. pp. 1423-1430. [Online].